Tesamorelin TSM5 5mg*10vials

Tesamorelin TSM5 5mg x 10 Vials

Product Overview

Tesamorelin TSM5 is an upgraded medium-potency modified growth hormone-releasing hormone analog research peptide, serving as an enhanced mid-range product in the TSM series, comprehensively optimized from the basic version TSM2. It retains the structurally modified molecular framework unique to Tesamorelin, maintaining enzymatic degradation resistance and stable endogenous GH and IGF-1 axis activation properties. It inherits the core advantage of targeting and regulating visceral and hepatic lipid metabolism, distinguishing it from ordinary Sermorelin. TSM5 uses a standard 5mg medium concentration and optimized molecular binding activity. Compared to low-dose TSM2, it supports lipolysis efficiency improvement research, adipose tissue remodeling studies, and endocrine metabolism improvement research, resulting in significant distinguishable experimental phenotypes. It is suitable for medium-gradient lipid metabolism studies, medium-intensity visceral fat ablation research, moderate fatty liver metabolic intervention studies, and complex peptide metabolism synergistic validation research. As a core mainstream upgrade product in the TSM series, it covers most mid-to-high-level preclinical research scenarios for obesity-related metabolic disorders and age-related lipodystrophy.

Core Research Functions

High-Amplitude Physiological Pulsatile GH Secretion and IGF-1 Upregulation: Supports high-amplitude physiological pulsatile growth hormone secretion stable triggering research and sustained insulin-like growth factor-1 upregulation studies, effectively activating mitochondrial metabolic activity and deep fat catabolism pathway research.

Abdominal Visceral Fat Targeted Breakdown and Hepatic Lipid Deposits Clearance: Supports abdominal visceral fat targeted breakdown efficacy improvement research, hepatic lipid deposits clearance studies, adipose tissue inflammation improvement research, and insulin sensitivity regulation research.

Deep Visceral Fat Reserves Reduction and Moderate Fatty Liver Metabolic Disorder Intervention: Supports deep visceral fat reserves reduction research, abnormal hepatic lipid metabolism improvement studies, and moderate fatty liver metabolic disorder reversal research.

Lean Tissue Maintenance and Anti-Aging Endocrine Repair: Supports moderate lean tissue maintenance enhancement research and anti-aging endocrine repair effect studies.

Natural Physiological Rhythm Activation Mechanism Adherence: Supports natural physiological rhythm activation mechanism adherence research, feedback inhibition and hormone desensitization related studies, and safe intervention and significant experimental efficacy balance research.

Compared to the mild baseline effect of TSM2, TSM5 exhibits comprehensively enhanced core metabolic functions in core research dimensions. TSM5 is suitable for medium-dose gradient mechanism exploration research, mid-term chronic metabolic remodeling modeling studies, and peptide combined efficacy validation research, providing high-discrimination reproducible data for lipid metabolism and metabolic syndrome intervention mechanism in-depth research.

Core Product Advantages

TSM5 Intermediate Enhanced Iteration: An intermediate-level upgrade of TSM2, optimizing molecular target activity and pathway affinity. It retains Tesamorelin unique lipid-targeting properties while supporting metabolic regulation intensity enhancement research, bridging the gap between mild low-dose basic research and high-intensity extreme interventions.

Enhanced Visceral and Liver Lipid Targeting: Building upon basic lipolysis targeting, it further supports deep fat and liver metabolic pathway activation efficiency enhancement research, achieving thorough visceral fat reduction and liver lipid clearance research, resolving low-dose version insignificant phenotypic differentiation related issue research.

Stable Modified Molecular Performance: Mature optimized structural modifications support durable anti-degradation stability research, achieving continuous stable metabolic signal activation research. It supports drastic hormonal fluctuations and endocrine imbalances related studies, suitable for long-term moderate-intensity chronic metabolic intervention studies.

5mg Balanced Medium-Acting Strength: The classic mainstream medium-acting strength in the TSM series, balancing experimental biosafety and significant efficacy. This product supports low-dose formulation insufficient metabolic improvement and ultra-high-dose intervention excessive physiological burden related problem research, suitable for most routine gradient experiments and complex peptide synergistic effect studies.

Pharmaceutical-Grade High Purity: Utilizing aseptic vacuum freeze-drying technology to support peptide peak activity stable retention research. Each batch undergoes rigorous HPLC purity testing and is accompanied by a complete Certificate of Analysis (COA). The 10-vial aseptic integrated packaging is suitable for medium-sized laboratory research, university key metabolic projects, and bulk wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 5mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).